Richard White is the Chief Operating Officer at Oxford PharmaGenesis Ltd. (Oxford, UK).
White founded the Oxford PharmaGenesis Value Demonstration and Patient Engagement Practices, to apply evidence-based communication best practice to clinical, real-world evidence, patient-reported outcome and patient preference studies.
White has run training workshops in the areas of health economics, outcomes research and real-world evidence for multiple pharmaceutical companies, and has also delivered invited presentations at various international conferences, including the Patient Engagement & Experience Summit, and the World Orphan Drug Congress.
White has authored various peer-reviewed publications and white papers on value demonstration, good publication practice and patient engagement. He holds a Master’s, as well as a Doctor of Philosophy, degree in Natural Sciences.